Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laughing gas may ease pain during physio for seniors

NCT ID NCT02230007

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a gas called MEOPA (laughing gas) can help elderly people manage pain during physiotherapy for stiff hips or knees. Six patients aged 65 or older received three sessions of physiotherapy with MEOPA or standard care. The goal was to see if the gas improved joint movement and reduced pain, offering a safer alternative to stronger painkillers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MEOPA (a gas mixture of nitrous oxide and oxygen, also known as laughing gas)
What this could lead to
If it works, this could offer a safer pain relief option for elderly patients during physiotherapy, reducing the need for stronger painkillers.
What could go wrong
This is a very small, completed Phase 4 trial with only 6 participants, so results may not apply to everyone. The gas may cause side effects like dizziness or nausea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

6 people

The number who actually took part.

Started

Sep 2013

Finished

Feb 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female aged 65 years old or more * Patients having a prescription for physiotherapy * Absence of contraindication to MEOPA * Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is ≥ 5 or ≥ 2 during mobilisation on the validated scale Algoplus * Patients whose reeducation project established by the physiotherapist * Patients having agreed to participate in the study and having signed the consent * Subjects affiliated to the social security system Exclusion Criteria: * Patient requiring a ventilation in pure oxygen * Patient with a consciousness deterioration preventing his cooperation * Care under MEOPA during the period of the protocol and during the month which precedes * Increase of the dosage of morphine of less than 48 hours Patient under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain management and care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Nice

    Nice, France

  • Pôle de Gérontologie Hôpital de Cimiez CHU de Nice

    Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.